Trial Profile
Randomized, double-blind, crossover study of Armodafinil assessing driving simulator performance of subjects with shift work disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary)
- Indications Circadian rhythm sleep disorders
- Focus Pharmacodynamics; Therapeutic Use
- 30 Oct 2015 New trial record